Ultragenyx
Statements
Cash Flow
Ultragenyx (RARE) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Operating Cash Flow" came in at -97 million USD. Tick rows to compare them in a chart.
All figures in millions of USD.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 16 | Q4 16 | Q1 17 | Q2 17 | Q3 17 | Q4 17 | Q1 18 | Q2 18 | Q3 18 | Q4 18 | Q1 19 | Q2 19 | Q3 19 | Q4 19 | Q1 20 | Q2 20 | Q3 20 | Q4 20 | Q1 21 | Q2 21 | Q3 21 | Q4 21 | Q1 22 | Q2 22 | Q3 22 | Q4 22 | Q1 23 | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -29 | -48 | -61 | -49 | -62 | -82 | -89 | -76 | -69 | -56 | -96 | -89 | -89 | -72 | -95 | 87 | -62 | -62 | -159 | -65 | -60 | -54 | -118 | -77 | -95 | -90 | -157 | -116 | -118 | -84 | -191 | -77 | -67 | -80 | -166 | -108 | -91 | -100 | -197 | -97 | -485 | |
| 1.0 | 1.2 | 1.2 | 1.1 | 1.1 | 2.5 | 6.2 | 6.1 | 4.4 | 2.9 | 2.1 | 2.1 | 2.1 | 2.2 | 2.9 | 3.2 | 3.1 | 3.1 | 3.4 | 3.1 | 3.2 | 3.5 | 4.1 | 4.5 | 4.7 | 5.0 | 5.2 | 5.4 | 7.2 | 8.2 | 8.8 | 8.9 | 8.8 | 9.1 | 9.0 | -12 | 8.6 | 8.8 | 8.0 | 8.0 | 33 | |
| 14 | 14 | 14 | 17 | 17 | 20 | 19 | 20 | 21 | 21 | 20 | 22 | 20 | 20 | 20 | 22 | 20 | 23 | 24 | 27 | 27 | 27 | 29 | 36 | 36 | 29 | 32 | 35 | 35 | 34 | 37 | 39 | 42 | 40 | 40 | 39 | 37 | 37 | 30 | 34 | 138 | |
| 14 | 55 | 14 | 13 | 13 | 63 | -106 | -20 | 21 | 21 | 21 | 22 | 21 | 20 | 0.5 | -0.4 | 0.1 | -50 | 0.3 | 64 | -0.1 | -0.2 | 0.0 | 0.4 | 75 | -1.0 | 0.2 | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| 20 | 7.0 | -8.5 | 9.7 | 2.4 | -24 | -19 | -8.9 | -6.0 | 9.3 | -21 | -2.1 | 5.9 | 1.4 | 2.9 | 127 | -34 | 8.6 | -77 | -9.8 | 3.1 | 21 | -12 | 28 | 22 | 22 | -38 | 7.2 | 2.8 | 15 | -56 | 16 | 31 | 23 | -57 | -22 | 55 | 0.6 | -51 | -29 | -25 | |
| 3.0 | 0.7 | 0.5 | 0.4 | 1.0 | 0.9 | 0.5 | 1.4 | 1.0 | 1.2 | 3.1 | 5.2 | 5.0 | 12 | 14 | 4.1 | 6.1 | 20 | 16 | 20 | 21 | 16 | 62 | 31 | 26 | 27 | 25 | 16 | 3.7 | 1.6 | 13 | 4.5 | 1.6 | 0.7 | 16 | 13 | 1.3 | 0.9 | 1.0 | 1.0 | 4.2 | |
| 53 | -8.4 | -9.4 | -21 | 30 | 57 | -71 | -52 | 16 | 74 | -101 | -58 | 79 | 67 | -95 | -86 | -96 | 98 | -182 | -41 | -41 | 69 | -37 | 79 | -162 | -172 | 111 | 99 | 64 | -107 | 94 | 61 | -276 | 103 | 120 | 71 | 117 | -72 | -49 | 44 | 40 | |
| 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| 4,668 | 0.0 | 1.4 | 1.5 | 1.3 | 0.0 | 275 | 13 | 9.2 | 1.8 | 334 | 3.8 | 0.9 | 1.2 | 0.4 | 15 | 19 | – | 13 | 13 | 7.7 | 6.9 | 1.8 | 6.0 | 1.1 | 2.0 | – | – | – | – | -0.1 | 0.1 | – | – | – | – | – | – | – | – | – | |
| – | -4.9 | -4.9 | -4.9 | -4.9 | -4.9 | – | – | – | – | – | 0.0 | 0.0 | 0.0 | 0.0 | -0.1 | -0.1 | 0.1 | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| 63 | 75 | 69 | 1.5 | 1.3 | 64 | 286 | 13 | 25 | 12 | 354 | 9.3 | 0.9 | 315 | 56 | 36 | 19 | 490 | 13 | 13 | 7.6 | 86 | 1.6 | 5.8 | 492 | 1.9 | -0.7 | 33 | 25 | 331 | -0.1 | 385 | 11 | 3.2 | 0.2 | 84 | 0.0 | 394 | – | 3.0 | – | |
| 87 | 19 | -1.6 | -69 | -30 | 40 | 126 | -116 | -28 | 30 | 156 | -138 | -8.8 | 311 | -135 | 37 | -138 | 526 | -330 | -94 | -93 | 100 | -153 | 6.5 | 234 | -259 | -46 | 16 | -29 | 141 | -97 | 368 | -330 | 24 | -45 | 49 | 26 | 222 | -251 | -49 | -52 | |
| -32 | -48 | -62 | -49 | -63 | -83 | -90 | -77 | -70 | -57 | -99 | -94 | -94 | -84 | -109 | 83 | -68 | -82 | -176 | -85 | -80 | -70 | -180 | -108 | -121 | -117 | -182 | -133 | -122 | -86 | -204 | -81 | -69 | -80 | -183 | -96 | -93 | -101 | -198 | -98 | -489 |
LTM = last twelve months (sum of the four most recent quarters).
Showing the most recent 40 periods — older statements are on file for this stock.
Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.